Fact based stock research
Oxford BioMedica (LSE:OXB)


Oxford BioMedica stock research in summary

oxfordbiomedica.co.uk


Oxford BioMedica shares have a market-typical stock price level. While they show above average growth, they are riskily financed, and are poor value. We recommend evaluating whether the future of the company Oxford BioMedica is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.


Latest Obermatt Ranks


Country United Kingdom
Industry Biotechnology
Index FTSE All Shares
Size class X-Small

August 16, 2019. Stock data may be delayed. Login to get the most recent research.


Research History: Oxford BioMedica

RESEARCH HISTORY 2016 2017 2018 2019
VALUE
VALUE
GROWTH
GROWTH
SAFETY
SAFETY
COMBINED
COMBINED

Last update of Combined Rank: 16-Aug-2019. Financial reporting date used for calculating ranks: 31-Dec-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better Oxford BioMedica is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2016 2017 2018 2019
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)
DIVIDEND YIELD
DIVIDEND YIELD
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE

Last update of Value Rank: 16-Aug-2019. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Oxford BioMedica; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2016 2017 2018 2019
REVENUE GROWTH
REVENUE GROWTH
PROFIT GROWTH
PROFIT GROWTH
STOCK RETURNS
STOCK RETURNS
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH

Last update of Growth Rank: 31-Dec-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Oxford BioMedica.


Safety Metrics in Detail

SAFETY METRICS 2016 2017 2018 2019
LEVERAGE
LEVERAGE
REFINANCING
REFINANCING
LIQUIDITY
LIQUIDITY
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY

Last update of Safety Rank: 9-Aug-2019. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Oxford BioMedica and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Oxford BioMedica from August 16, 2019.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.

Register for
stock tips now


Stock investing made easy